API Product   :    Rivastigmine HCI
CEP   :    -
WCC   :    ?
Therapeutic Use    :    Psychoanaleptics Excluding Anti-Obesity Preparations; Other CNS Drugs
Psychoanaleptics Excluding Anti-Obesity Preparations; Other CNS Drugs
Originator   :    Novartis
CAS No.    :    123441-03-2
Trade Name.   :    EXELON
Molecular Weight   :    250.337 g/mol
Molecular Formula   :    C14H22N2O2
Rivastigmine capsules, liquid solution and patches are used for the treatment of mild to moderate dementia of the Alzheimer's type and for mild to moderate dementia related to Parkinson's disease.
Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting. The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions.